NCT06774651

Brief Summary

This observational study aims to compare two laser corrective procedures for treating myopia and myopic astigmatism: a novel refractive technique, the CLEAR procedure, and the established SMILE procedure. Participants will be randomized to undergo CLEAR in one eye and SMILE in the other. The investigators will evaluate and compare the two procedures based on the following aspects: refractive predictability (how accurate the vision correction is) by measuring the proportion of eyes close to the target prescription after surgery, clinical dry eye outcomes, changes in tear proteins, and corneal nerve changes at 1, 3, 6, and 12 months after both surgeries. Metabolomic features of the removed corneal tissue and how precisely the laser is centered during surgery will also be examined. Our hypothesis is that CLEAR provides equally good vision results as SMILE, and explore any extra benefits of CLEAR.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
65

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2023

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

December 30, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 14, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

January 14, 2025

Status Verified

December 1, 2024

Enrollment Period

2.7 years

First QC Date

December 30, 2024

Last Update Submit

January 8, 2025

Conditions

Keywords

CLEARFEMTO LDV Z8SMILEVisumaxMyopia

Outcome Measures

Primary Outcomes (1)

  • Rate of refractive predictability

    Refractive predictability is defined as the proportion number of eyes achieving a postoperative spherical equivalent (SE) within ±1.0 D of the intended target. Uncorrected visual acuity (UCVA), refraction, and best corrected visual acuity (BCVA) will be recorded.

    1 year

Secondary Outcomes (14)

  • Level of higher order aberrations

    1 year

  • Tear Break Up Time (TBUT)

    1 year

  • Concentration of tear neuromediators assessed by enzyme-linked immunosorbent assay

    1 year

  • Corneal sensitivity measurements assessed by Cochet-Bonnet esthesiometer

    1 year

  • NEI score

    1 year

  • +9 more secondary outcomes

Study Arms (2)

1. CLEAR surgery eyes

Eyes that have undergone CLEAR procedures.

Procedure: Procedure: Corneal lenticule extraction for advanced refractive correction (CLEAR)

2. SMILE surgery eyes

Eyes that have undergone SMILE procedures.

Procedure: Procedure: Small Incision Lenticule Extraction (SMILE)

Interventions

Routinely conducted procedure using FEMTO LDV Z8 laser system for correction of Myopia.

1. CLEAR surgery eyes

Routinely conducted procedure using VisuMax laser system for correction of Myopia.

Also known as: SMILE
2. SMILE surgery eyes

Eligibility Criteria

Age21 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

A total of 65 subjects (130 eyes- 65 CLEAR eyes and 65 SMILE eyes) will be recruited in the study from refractive clinic at Singapore National Eye Centre.

You may qualify if:

  • \>/= 21 years of age and \</= 50 years of age.
  • Cycloplegic spherical equivalent of \>-1.00D
  • Refractive cylinder -2.00 D or less; anisometropia \<1.00D
  • Best spectacle corrected visual acuity (BSCVA) of 6/12 or better in BOTH eyes.
  • Spherical or cylindrical error has progressed at -0.50D or less per year from date of baseline measurement.
  • Contact lens wearers must have removed contact lenses at least two (2) weeks before the baseline measurement.
  • No evidence of irregular astigmatism on corneal topography.
  • Available to attend post-operative examinations for a 12-month period.

You may not qualify if:

  • Progressive or unstable myopia and/or astigmatism.
  • Clinical or corneal topographic evidence of keratoconus.
  • Patients who want bilateral SMILE procedure
  • Patients who want extracted corneal lenticule to be stored for future refractive surgery.
  • Residual, recurrent or active ocular disease such as uveitis, severe dry eyes, severe allergic eye disease, glaucoma, visually significant cataract and retinal disease.
  • Previous corneal surgery or trauma within the corneal treatment zone.
  • Corneal vascularisation within 1mm of the corneal treatment zone.
  • Taking systemic medications likely to affect wound healing, such as corticosteroids and antimetabolites.
  • Systemically immunocompromised.
  • Systemic disease likely to affect wound healing, such as diabetes, connective tissue disease and severe atopy.
  • Pregnant or nursing.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Singapore National Eye Centre

Singapore, S169856, Singapore

RECRUITING

Related Publications (1)

  • Yu M, Liu C, Lee IXY, Hsu VW, Wong RKT, Anam A, Lim R, Mehta JS, Liu YC. Randomized controlled trial on corneal denervation, neuroinflammation and ocular surface in corneal lenticule extraction for advanced refractive correction (CLEAR) and small incision lenticule extraction (SMILE). Eye Vis (Lond). 2025 Apr 1;12(1):12. doi: 10.1186/s40662-025-00429-1.

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Officials

  • Jodhbir S Mehta, MD, FRCS

    Singapore National Eye Centre

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jodhbir S Mehta, MD, FRCS

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 30, 2024

First Posted

January 14, 2025

Study Start

March 1, 2023

Primary Completion

October 31, 2025

Study Completion

December 31, 2025

Last Updated

January 14, 2025

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations